Is a hemorrhoidectomy (surgical removal of hemorrhoids) always necessary for histopathological examination in patients with hemorrhoidal disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemorrhoidectomy for Histopathological Examination

No, hemorrhoidectomy is not always necessary for histopathological examination—routine histopathology of hemorrhoid specimens is not recommended due to the extremely low incidence of malignancy (0.13%) and lack of impact on postoperative management in the vast majority of cases. 1, 2

Evidence Against Routine Histopathology

The most recent systematic review and meta-analysis of 48,365 hemorrhoidectomy specimens found that anal cancer was detected in only 0.13% (95% CI: 0.05%-0.31%) of cases, and combined anal cancer with anal intraepithelial neoplasia (AIN) occurred in just 1.16% (95% CI: 0.53%-2.52%) of specimens. 2

  • A large retrospective study of 914 hemorrhoidectomy specimens found histologic abnormalities in only 1.4% of cases, and critically, none of these findings altered postoperative management. 1

  • The low incidence of malignant findings suggests that routine histopathological analysis of hemorrhoidectomy samples is not cost-effective. 2

Clinical Implications for Practice

Hemorrhoidectomy should be performed based on clinical indications—not for the purpose of obtaining tissue for histopathology. The American Gastroenterological Association recommends surgical hemorrhoidectomy for:

  • Large third-degree or fourth-degree hemorrhoids 3
  • Acutely incarcerated and thrombosed hemorrhoids 3
  • Hemorrhoids with extensive symptomatic external components 3
  • Failure of less aggressive therapy 3
  • Mixed internal and external hemorrhoids requiring definitive treatment 4

When Histopathology May Be Warranted

While routine histopathology is unnecessary, selective examination should be considered when clinical features raise suspicion for alternative pathology:

  • Atypical appearance of tissue at time of excision 5
  • Unusual bleeding patterns not consistent with typical hemorrhoidal disease 5
  • Presence of anal pain (which is generally not associated with uncomplicated hemorrhoids and suggests other pathology such as anal fissure, abscess, or malignancy) 4
  • Patient age over 60 years with concerning features 1
  • Off-midline lesions that could represent Crohn's disease, HIV/AIDS, ulcerative colitis, tuberculosis, syphilis, leukemia, or cancer 4

Important Diagnostic Caveats

Never assume all anorectal symptoms are due to hemorrhoids—a directed physical examination including anoscopy and proctosigmoidoscopy should be performed to rule out other conditions. 3, 5

  • Hemorrhoids alone do not cause positive stool guaiac tests; fecal occult blood should not be attributed to hemorrhoids until the colon is adequately evaluated. 4, 5
  • Anemia from hemorrhoidal disease is rare (0.5 patients per 100,000 population) and should prompt colonoscopy to exclude proximal colonic pathology. 4, 5
  • Significant anal pain is not typical of uncomplicated hemorrhoids and warrants investigation for anal fissure (present in up to 20% of patients with hemorrhoids), abscess, or thrombosis. 4

Cost-Effectiveness Considerations

The existing literature has not established definitive risk factors for abnormal histological diagnoses that would justify selective histopathology protocols. 2 Given the extremely low yield of clinically significant findings and the lack of impact on postoperative management in 98.6% of cases 1, routine histopathological examination represents an unnecessary healthcare expenditure without meaningful benefit to patient outcomes in terms of morbidity, mortality, or quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hemorrhoids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Referral Guidelines for Hemorrhoid Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the treatment for a 35-year-old postpartum woman with a painful thrombosed external hemorrhoid at the anal verge, who does not tolerate a rectal exam?
What's the next step in management for a 46-year-old patient with hemorrhoids presenting with fresh blood upon defecation or on their underwear and significant anemia with a hemoglobin (Hb) level of 10-11 g/dL?
What is the management for a patient with prolapsed hemorrhoids (hemorrhoids) that are irreducible except by manual reduction, presenting with anal swelling and bleeding?
What is the initial management for a 30-year-old female with a painful bleeding external hemorrhoid?
What is the recommended treatment for acute hemorrhoids?
What is the likely diagnosis for an adult patient with chronic chest discomfort and lung pain, no cardiac issues, and abnormal results on High-Resolution Computed Tomography (HRCT), Pulmonary Function Tests (PFT), and Diffusing Capacity of the Lung for Carbon Monoxide (DLCO)?
Is clotrimazole (antifungal medication) an acceptable treatment option for an adult or child with mild to moderate ringworm and no known allergies to clotrimazole?
What is the recommended treatment approach for a 30-year-old adult patient with meduloblastoma harboring a Hedgehog pathway mutation, who has undergone macroscopically complete resection but shows residual images on magnetic resonance imaging (MRI)?
Should a beta (beta blocker) be discontinued in a patient with hyperkalemia (elevated potassium levels) who is taking a beta blocker, such as propranolol (propranolol) or metoprolol (metoprolol), especially with impaired renal function?
What is the recommended dose of doxycycline (tetracycline antibiotic) for a patient with normal renal function and no contraindications, diagnosed with an Extended-Spectrum Beta-Lactamase (ESBL) Urinary Tract Infection (UTI)?
What is the recommended initial dose and treatment approach for a patient with type 2 diabetes or insulin resistance starting on metformin (biguanide), considering potential kidney disease, liver disease, gastrointestinal issues, or vitamin B12 deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.